SlideShare une entreprise Scribd logo
1  sur  7
Télécharger pour lire hors ligne
Biosimilars - Regulatory Framework And Pipeline Analysis
MarketResearchReports.Biz presents this most up-to-date research on "Biosimilars -
Regulatory Framework And Pipeline Analysis"
Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared
with innovative biologic products. Biosimilars are getting the world wide attention as the
cost of the innovative biologics are enormously high and even minimal reduction in price
will reduce the healthcare spending substantially. All the countries are focusing on
reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic
products are complex in structure and follow a complex manufacturing process thus, some
variation exists between the reference product and its biosimilar. It is very important to
assess the variations in biosimilars by comparing with reference product to ensure quality,
non-clinical, and clinical properties, which has given rise to the regulatory requirements for
biosimilars.
Regulatory requirement for approving biosimilars varies across different regulatory bodies.
However, all the countries have derived the basic theme from EMA and WHO guidelines for
framing their regulatory structure. There is a need to harmonize the nomenclature of
biosimilars, extrapolation of indications, and interchangeability of biosimilars with
reference products across the regulatory bodies. Biosimilars market is developing and it
could be well established with the pipeline that is poised to deliver a wave of biosimilars in
the market in the near future
Get The Sample Copy Of This Report:
http://www.marketresearchreports.biz/sample/sample/286559
Scope
The scope of the report includes:
Introduction
Market dynamics: Trends, Drivers, and Barriers
WHO guidance for biosimilars
Regulatory overview, biosimilar guidelines, regulatory framework for biosimilars, and
market outlook for:
Europe
USA
India
South Korea
Japan
China
Key players
Pipeline Analysis
Overview
By Stage of Development / Molecule / Therapy Area / Indication
Late-Stage / Phase II / Phase I Pipeline Biosimilars
Reasons To Buy
The report will enhance your decision-making capability by allowing you to:
Understand the regulatory requirement and regulatory framework that facilitates effective
product development strategy as biosimilars industry is currently highly focused, growing,
and outpacing the growth rate of small molecule pharmaceutical market
Targeting geographies would be easy by comparing different regulatory frameworks; this
would also provide a base for designing a strategy to enter the developed markets.
Biosimilars are of interest in developed countries to reduce the healthcare expenditure
With the recent approvals of biosimilars by USFDA, the biosimilars market is going to grow
and this report examines the post approval market landscape
Examine the biosimilars pipeline and specifies the products that are highly targeted, it also
includes analysis of highly focused indications, mechanism of actions, and therapy areas
in the pipeline
Analyze the details of the clinical pipeline that includes late stage products, Phase II, and
Phase I products. Detailed understanding of the pipeline will help in targeting the products
for development, rate the current products and predict the competition
About us
MarketResearchReports.biz is the most comprehensive collection of market
research reports. MarketResearchReports.Biz services are specially designed to
save time and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports, custom
research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.
To View The Top Related News:
http://www.marketresearchreports.biz/articles
Contact US:
Office: United States
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Toll Free: 866-997-4948
Tel: +1-518-618-1030
E: sales@marketresearchreports.biz

Contenu connexe

En vedette

The 5 Metrics for Growing Your Team Effectively
The 5 Metrics for Growing Your Team EffectivelyThe 5 Metrics for Growing Your Team Effectively
The 5 Metrics for Growing Your Team EffectivelySales Hacker
 
Sales Hacker Workshop SF: Build a High Velocity Sales Machine
Sales Hacker Workshop SF: Build a High Velocity Sales MachineSales Hacker Workshop SF: Build a High Velocity Sales Machine
Sales Hacker Workshop SF: Build a High Velocity Sales MachineSales Hacker
 
Writing data analysis pipeline as ruby gem
Writing data analysis pipeline as ruby gemWriting data analysis pipeline as ruby gem
Writing data analysis pipeline as ruby gemSean S.G Wang
 
General pipeline of transcriptomics analysis
General pipeline of transcriptomics analysisGeneral pipeline of transcriptomics analysis
General pipeline of transcriptomics analysisSanty Marques-Ladeira
 
Visualising Data with Code
Visualising Data with CodeVisualising Data with Code
Visualising Data with CodeRi Liu
 
Working With Big Data
Working With Big DataWorking With Big Data
Working With Big DataSeth Familian
 
Analytics Trends 2016: The next evolution
Analytics Trends 2016: The next evolutionAnalytics Trends 2016: The next evolution
Analytics Trends 2016: The next evolutionDeloitte United States
 
Booz Allen Field Guide to Data Science
Booz Allen Field Guide to Data Science Booz Allen Field Guide to Data Science
Booz Allen Field Guide to Data Science Booz Allen Hamilton
 

En vedette (9)

Service marketing - Critical Analysis of Goibibo Services
Service marketing - Critical Analysis of Goibibo ServicesService marketing - Critical Analysis of Goibibo Services
Service marketing - Critical Analysis of Goibibo Services
 
The 5 Metrics for Growing Your Team Effectively
The 5 Metrics for Growing Your Team EffectivelyThe 5 Metrics for Growing Your Team Effectively
The 5 Metrics for Growing Your Team Effectively
 
Sales Hacker Workshop SF: Build a High Velocity Sales Machine
Sales Hacker Workshop SF: Build a High Velocity Sales MachineSales Hacker Workshop SF: Build a High Velocity Sales Machine
Sales Hacker Workshop SF: Build a High Velocity Sales Machine
 
Writing data analysis pipeline as ruby gem
Writing data analysis pipeline as ruby gemWriting data analysis pipeline as ruby gem
Writing data analysis pipeline as ruby gem
 
General pipeline of transcriptomics analysis
General pipeline of transcriptomics analysisGeneral pipeline of transcriptomics analysis
General pipeline of transcriptomics analysis
 
Visualising Data with Code
Visualising Data with CodeVisualising Data with Code
Visualising Data with Code
 
Working With Big Data
Working With Big DataWorking With Big Data
Working With Big Data
 
Analytics Trends 2016: The next evolution
Analytics Trends 2016: The next evolutionAnalytics Trends 2016: The next evolution
Analytics Trends 2016: The next evolution
 
Booz Allen Field Guide to Data Science
Booz Allen Field Guide to Data Science Booz Allen Field Guide to Data Science
Booz Allen Field Guide to Data Science
 

Dernier

Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...panagenda
 
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPTiSEO AI
 
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo DiehlFuture Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo DiehlPeter Udo Diehl
 
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...marcuskenyatta275
 
Optimizing NoSQL Performance Through Observability
Optimizing NoSQL Performance Through ObservabilityOptimizing NoSQL Performance Through Observability
Optimizing NoSQL Performance Through ObservabilityScyllaDB
 
How we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdfHow we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdfSrushith Repakula
 
Easier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties ReimaginedEasier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties Reimaginedpanagenda
 
PLAI - Acceleration Program for Generative A.I. Startups
PLAI - Acceleration Program for Generative A.I. StartupsPLAI - Acceleration Program for Generative A.I. Startups
PLAI - Acceleration Program for Generative A.I. StartupsStefano
 
What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024Stephanie Beckett
 
Salesforce Adoption – Metrics, Methods, and Motivation, Antone Kom
Salesforce Adoption – Metrics, Methods, and Motivation, Antone KomSalesforce Adoption – Metrics, Methods, and Motivation, Antone Kom
Salesforce Adoption – Metrics, Methods, and Motivation, Antone KomCzechDreamin
 
Microsoft CSP Briefing Pre-Engagement - Questionnaire
Microsoft CSP Briefing Pre-Engagement - QuestionnaireMicrosoft CSP Briefing Pre-Engagement - Questionnaire
Microsoft CSP Briefing Pre-Engagement - QuestionnaireExakis Nelite
 
Google I/O Extended 2024 Warsaw
Google I/O Extended 2024 WarsawGoogle I/O Extended 2024 Warsaw
Google I/O Extended 2024 WarsawGDSC PJATK
 
Oauth 2.0 Introduction and Flows with MuleSoft
Oauth 2.0 Introduction and Flows with MuleSoftOauth 2.0 Introduction and Flows with MuleSoft
Oauth 2.0 Introduction and Flows with MuleSoftshyamraj55
 
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdfLinux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdfFIDO Alliance
 
AI presentation and introduction - Retrieval Augmented Generation RAG 101
AI presentation and introduction - Retrieval Augmented Generation RAG 101AI presentation and introduction - Retrieval Augmented Generation RAG 101
AI presentation and introduction - Retrieval Augmented Generation RAG 101vincent683379
 
The Metaverse: Are We There Yet?
The  Metaverse:    Are   We  There  Yet?The  Metaverse:    Are   We  There  Yet?
The Metaverse: Are We There Yet?Mark Billinghurst
 
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...FIDO Alliance
 
Structuring Teams and Portfolios for Success
Structuring Teams and Portfolios for SuccessStructuring Teams and Portfolios for Success
Structuring Teams and Portfolios for SuccessUXDXConf
 
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)Julian Hyde
 

Dernier (20)

Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
Easier, Faster, and More Powerful – Alles Neu macht der Mai -Wir durchleuchte...
 
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT
1111 ChatGPT Prompts PDF Free Download - Prompts for ChatGPT
 
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo DiehlFuture Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
Future Visions: Predictions to Guide and Time Tech Innovation, Peter Udo Diehl
 
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...
TEST BANK For, Information Technology Project Management 9th Edition Kathy Sc...
 
Optimizing NoSQL Performance Through Observability
Optimizing NoSQL Performance Through ObservabilityOptimizing NoSQL Performance Through Observability
Optimizing NoSQL Performance Through Observability
 
How we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdfHow we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdf
 
Easier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties ReimaginedEasier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties Reimagined
 
PLAI - Acceleration Program for Generative A.I. Startups
PLAI - Acceleration Program for Generative A.I. StartupsPLAI - Acceleration Program for Generative A.I. Startups
PLAI - Acceleration Program for Generative A.I. Startups
 
What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024
 
Salesforce Adoption – Metrics, Methods, and Motivation, Antone Kom
Salesforce Adoption – Metrics, Methods, and Motivation, Antone KomSalesforce Adoption – Metrics, Methods, and Motivation, Antone Kom
Salesforce Adoption – Metrics, Methods, and Motivation, Antone Kom
 
Microsoft CSP Briefing Pre-Engagement - Questionnaire
Microsoft CSP Briefing Pre-Engagement - QuestionnaireMicrosoft CSP Briefing Pre-Engagement - Questionnaire
Microsoft CSP Briefing Pre-Engagement - Questionnaire
 
Google I/O Extended 2024 Warsaw
Google I/O Extended 2024 WarsawGoogle I/O Extended 2024 Warsaw
Google I/O Extended 2024 Warsaw
 
Oauth 2.0 Introduction and Flows with MuleSoft
Oauth 2.0 Introduction and Flows with MuleSoftOauth 2.0 Introduction and Flows with MuleSoft
Oauth 2.0 Introduction and Flows with MuleSoft
 
Overview of Hyperledger Foundation
Overview of Hyperledger FoundationOverview of Hyperledger Foundation
Overview of Hyperledger Foundation
 
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdfLinux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
Linux Foundation Edge _ Overview of FDO Software Components _ Randy at Intel.pdf
 
AI presentation and introduction - Retrieval Augmented Generation RAG 101
AI presentation and introduction - Retrieval Augmented Generation RAG 101AI presentation and introduction - Retrieval Augmented Generation RAG 101
AI presentation and introduction - Retrieval Augmented Generation RAG 101
 
The Metaverse: Are We There Yet?
The  Metaverse:    Are   We  There  Yet?The  Metaverse:    Are   We  There  Yet?
The Metaverse: Are We There Yet?
 
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
 
Structuring Teams and Portfolios for Success
Structuring Teams and Portfolios for SuccessStructuring Teams and Portfolios for Success
Structuring Teams and Portfolios for Success
 
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
Measures in SQL (a talk at SF Distributed Systems meetup, 2024-05-22)
 

Biosimilars Industry Analysis - Market Size, Shares, Trends, Growth, Forecast, Regulatory Framework And Pipeline Analysis

  • 1. Biosimilars - Regulatory Framework And Pipeline Analysis MarketResearchReports.Biz presents this most up-to-date research on "Biosimilars - Regulatory Framework And Pipeline Analysis" Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even minimal reduction in price
  • 2. will reduce the healthcare spending substantially. All the countries are focusing on reducing the healthcare expenditure and biosimilars compliments to this goal. Biologic products are complex in structure and follow a complex manufacturing process thus, some variation exists between the reference product and its biosimilar. It is very important to assess the variations in biosimilars by comparing with reference product to ensure quality, non-clinical, and clinical properties, which has given rise to the regulatory requirements for biosimilars. Regulatory requirement for approving biosimilars varies across different regulatory bodies. However, all the countries have derived the basic theme from EMA and WHO guidelines for framing their regulatory structure. There is a need to harmonize the nomenclature of biosimilars, extrapolation of indications, and interchangeability of biosimilars with reference products across the regulatory bodies. Biosimilars market is developing and it could be well established with the pipeline that is poised to deliver a wave of biosimilars in the market in the near future
  • 3. Get The Sample Copy Of This Report: http://www.marketresearchreports.biz/sample/sample/286559 Scope The scope of the report includes: Introduction Market dynamics: Trends, Drivers, and Barriers WHO guidance for biosimilars Regulatory overview, biosimilar guidelines, regulatory framework for biosimilars, and market outlook for: Europe USA India South Korea Japan
  • 4. China Key players Pipeline Analysis Overview By Stage of Development / Molecule / Therapy Area / Indication Late-Stage / Phase II / Phase I Pipeline Biosimilars Reasons To Buy The report will enhance your decision-making capability by allowing you to: Understand the regulatory requirement and regulatory framework that facilitates effective product development strategy as biosimilars industry is currently highly focused, growing, and outpacing the growth rate of small molecule pharmaceutical market Targeting geographies would be easy by comparing different regulatory frameworks; this would also provide a base for designing a strategy to enter the developed markets. Biosimilars are of interest in developed countries to reduce the healthcare expenditure
  • 5. With the recent approvals of biosimilars by USFDA, the biosimilars market is going to grow and this report examines the post approval market landscape Examine the biosimilars pipeline and specifies the products that are highly targeted, it also includes analysis of highly focused indications, mechanism of actions, and therapy areas in the pipeline Analyze the details of the clinical pipeline that includes late stage products, Phase II, and Phase I products. Detailed understanding of the pipeline will help in targeting the products for development, rate the current products and predict the competition About us MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom
  • 6. research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries. To View The Top Related News: http://www.marketresearchreports.biz/articles Contact US: Office: United States State Tower 90 State Street, Suite 700
  • 7. Albany, NY 12207 United States Toll Free: 866-997-4948 Tel: +1-518-618-1030 E: sales@marketresearchreports.biz